Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
作者信息
Al Sulaiman Khalid, Aljuhani Ohoud, Badreldin Hisham A, Korayem Ghazwa B, Alenazi Abeer A, Alharbi Ahlam H, Alghamdi Albandari, Alhubaishi Alaa, Altebainawi Ali F, Bosaeed Mohammad, Alotaibi Rand, Alawad Ahad, Alnajjar Nirvana, Saleh Khalid Bin, Sait Walaa A, Alsohimi Samiah, Alanizy Meshari M, Almuqbil Sarah A, Al Sulaihim Ibrahim, Vishwakarma Ramesh, Alalawi Mai, Alhassan Fatimah, Alghnam Suliman
机构信息
Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Afairs (MNGHA), Riyadh, Saudi Arabia.
College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
出版信息
BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8.
Abstract
摘要
相似文献
1
Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.更正：新型冠状病毒肺炎危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8.
2
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.COVID-19 危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8.
3
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.评价吸入一氧化氮（iNO）治疗 COVID-19 重症危重症患者中中重度急性呼吸窘迫综合征（ARDS）的效果：一项多中心队列研究。
Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y.
4
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.新冠肺炎危重症患者新发心房颤动的发生率及临床转归：一项多中心队列研究——新发心房颤动与 COVID-19。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231156178. doi: 10.1177/10760296231156178.
5
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.中国新型冠状病毒传染病（COVID-19）危重症患者的临床特征和结局：一项回顾性多中心研究。
Intensive Care Med. 2020 Oct;46(10):1863-1872. doi: 10.1007/s00134-020-06211-2. Epub 2020 Aug 20.
6
Comparison of Clinical Findings in SARS-CoV-2 with Other Respiratory Viruses in Critically Ill Children during the COVID-19 Pandemic.COVID-19 大流行期间危重症儿童中 SARS-CoV-2 与其他呼吸道病毒的临床特征比较。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab102.
7
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.托珠单抗治疗 COVID-19 老年危重症患者的安全性和有效性：一项多中心队列研究。
Int J Infect Dis. 2022 Sep;122:252-259. doi: 10.1016/j.ijid.2022.05.038. Epub 2022 May 20.
8
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.评价 COVID-19 重症患者低剂量阿司匹林的使用：一项多中心倾向评分匹配研究。
J Intensive Care Med. 2022 Sep;37(9):1238-1249. doi: 10.1177/08850666221093229. Epub 2022 Apr 21.
9
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study.《2019 年冠状病毒病（COVID-19）危重症患者的临床特征和结局：一项多中心队列研究》
Int J Infect Dis. 2021 Apr;105:180-187. doi: 10.1016/j.ijid.2021.02.037. Epub 2021 Feb 15.
10
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study.COVID-19 感染危重症患者的气胸：一项病例对照多中心研究的发生率、临床特征和结局。
Respir Med. 2021 Aug;184:106464. doi: 10.1016/j.rmed.2021.106464. Epub 2021 May 13.
引用本文的文献
1
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).在 COVID-19 大流行期间的呼吸道病毒合并感染：2/3 期 molnupiravir 试验（MOVe-OUT）的流行病学分析和临床结局。
Microbiol Spectr. 2024 Mar 5;12(3):e0356323. doi: 10.1128/spectrum.03563-23. Epub 2024 Feb 1.
2
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.托珠单抗在 COVID-19 合并肾功能损害重症患者中的应用：一项多中心队列研究。
Ren Fail. 2023;45(2):2268213. doi: 10.1080/0886022X.2023.2268213. Epub 2023 Oct 23.
本文引用的文献
1
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.COVID-19 危重症患者合并其他呼吸道病毒感染的临床结局：一项多中心队列研究。
BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8.
Zotero 插件